The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2020
DOI: 10.1016/j.acthis.2019.151453
|View full text |Cite
|
Sign up to set email alerts
|

Clenbuterol accelerates recovery after immobilization-induced atrophy of rat hindlimb muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 35 publications
3
4
0
Order By: Relevance
“…Various models of sarcopenia have been previously used, such as denervation, cast immobilization, and hindlimb unloading [38]. Previous studies have shown that hindlimbimmobilization significantly reduced muscle mass, exercise endurance, grip strength, and muscle fiber CSA [43][44][45]. Our study showed similar changes, and, thus, we verified the pathogenesis of sarcopenia by hindlimb immobilization.…”
Section: Discussionsupporting
confidence: 84%
“…Various models of sarcopenia have been previously used, such as denervation, cast immobilization, and hindlimb unloading [38]. Previous studies have shown that hindlimbimmobilization significantly reduced muscle mass, exercise endurance, grip strength, and muscle fiber CSA [43][44][45]. Our study showed similar changes, and, thus, we verified the pathogenesis of sarcopenia by hindlimb immobilization.…”
Section: Discussionsupporting
confidence: 84%
“…Recent studies showed that immobilization significantly reduced muscle strength, mass, and the CSA of muscle fiber [33,43]. Our findings showed a significant decline in those mentioned above and also total protein content.…”
Section: Discussionsupporting
confidence: 70%
“…While the misuse of β 2 ‐agonists (including clenbuterol) as an image‐ and performance‐enhancement drug has been documented within the athletic community [45], the mechanisms by which these sympathomimetic agents confer muscle growth and reduce atrophy are ill‐defined [46]. Recent studies have identified increased myonuclear accretion in fast‐twitch muscles of adult male rats [47], as well as elevated cAMP/PKA and Akt2 signaling in resistance‐trained young male adults [48] as putative molecular adaptations. Whether these mechanisms are conserved during the neonatal stage of muscle development must be further investigated to establish concrete insights into β 2 ‐agonists as a potential therapy for reversing muscle wasting in younger patients.…”
Section: Discussionmentioning
confidence: 99%